Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
5.43
-0.02 (-0.37%)
At close: Aug 27, 2026, 4:00 PM EDT
5.43
0.00 (0.00%)
After-hours: Aug 27, 2026, 6:30 PM EDT
Armata Pharmaceuticals Market Cap
Armata Pharmaceuticals has a market cap or net worth of $201.9 million as of August 27, 2026. Its market cap has increased by 114.75% in one year.
Market Cap
201.90M
Enterprise Value
491.90M
1-Year Change
114.75%
Ranking
Category
Stock Price
$5.43
ChartMarket Cap Chart
Since May 10, 2019, Armata Pharmaceuticals's market cap has increased from $46.31M to $201.90M, an increase of 335.93%. That is a compound annual growth rate of 22.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 201.90M | -11.69% |
| Dec 31, 2025 | 228.64M | 241.56% |
| Dec 31, 2024 | 66.94M | -42.84% |
| Dec 29, 2023 | 117.11M | 161.30% |
| Dec 30, 2022 | 44.82M | -69.80% |
| Dec 31, 2021 | 148.43M | 165.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Coherus Oncology | 210.12M |
| Conexeu Sciences | 208.98M |
| Corbus Pharmaceuticals Holdings | 206.76M |
| Innate Pharma | 205.82M |
| Satellos Bioscience | 203.85M |
| Oramed Pharmaceuticals | 200.50M |
| Protalix BioTherapeutics | 194.18M |
| Korro Bio | 192.46M |